IDEAYA Biosciences, Inc.
IDYANASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $3.33B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $26.81$42.68
- Volume (live)
- -
- Avg. volume (3M)
- 858.64K
IDEAYA Biosciences (IDYA) Stock Price & Financial Analysis
IDEAYA Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $35.02 - $36.20 |
|---|---|
| 52-Week High | $42.68 |
| 52-Week Low | $26.81 |
| Open | $35.02 |
| Volume (last close) | 603.13K |
| Average Volume (3M) | 858.64K |
| Revenue (TTM) | 234.13M |
|---|---|
| Net Income (TTM) | -175.02M |
| Free Cash Flow (TTM) | -113.87M |
| EPS (TTM) | −$1.95 |
| Profit Margin | -74.75% |
| Operating Margin | -92.66% |
| Return on Equity (ROE) | -14.60% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 3.33B |
|---|---|
| Shares Outstanding | 92.06M |
| Price to Sales (P/S) | 14.20 |
| Price to Book (P/B) | 2.77 |
| EV/EBITDA | -14.48 |
| 50-Day MA | $37.80 |
|---|---|
| 200-Day MA | $34.12 |
| 1-Year Change | +27.09% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
IDEAYA Biosciences at a Glance
As of the Oct 22, 2026 close, IDEAYA Biosciences (IDYA) has a market capitalization of $3.33B. The stock trades at 14.2× sales. Over the trailing twelve months it lost $175.02M on revenue of $234.13M and burned $113.87M of free cash flow. Revenue grew 3244.7% year over year.
As of its latest reported balance sheet, it holds $272.59M in cash and securities against $29.31M of debt, a net cash position of $243.28M.
IDEAYA Biosciences does not currently pay a dividend.
The share price is up 27.1% over the past year. At $36.12 (the Oct 22, 2026 close) it sits within its 52-week range of $26.81 to $42.68, above its 200-day moving average of $34.12.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $53.55, 48.3% above the Oct 22, 2026 close.
Frequently Asked Questions About IDEAYA Biosciences
What is the current stock price for IDYA?
As of the Oct 22, 2026 close, IDYA stock trades at $36.12. The 52-week range is $26.81–$42.68, with a day range of $35.02–$36.20.
What is the P/E ratio for IDYA?
The P/E ratio (Price-to-Earnings) for IDYA is shown in the Key Statistics section. This valuation metric helps compare IDEAYA Biosciences, Inc. to industry peers.
Does IDYA pay dividends?
IDEAYA Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IDYA?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for IDYA is Buy. The average 12-month price target is $53.55, a 48.3% upside from the Oct 22, 2026 close of $36.12.
What is the market cap of IDYA?
As of the Oct 22, 2026 close, IDEAYA Biosciences's market capitalization is $3.33B, classifying it as a mid-cap company. IDEAYA Biosciences operates in the Healthcare sector within the Biotechnology industry.